利德曼 (300289)

BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.

ASZ

Tags

New QFII HoldingsMedical DevicesGene ConceptEquity TransferAssisted ReproductionRestructuring ProposalsCSI 2000 IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexCOVID-19 PreventionMilitary PartsGene SequencingGuangdong State-owned Assets ReformExpected Loss/DeclineQFII HoldingsPrivate PlacementHuijin ConceptShareholding Increase CommitmentExpected Profit/IncreaseCNI 2000 IndexSZSE Composite IndexNew IndexEmerging Industries Composite IndexManufacturing Index

K-Line Chart

No K-line data available

Company NameBeijing Leadman Biochemistry Co., Ltd.
Listing Date2012-02-16
Issue Price13RMB
Registered Capital54401.148710k RMB
Legal RepresentativeYao Zi
Registered AddressNo. 5 Xinghai Road, Beijing Economic-Technological Development Area, Beijing
IndustryMedical Devices
Main BusinessPossesses core competitiveness in the fields of in vitro diagnostic products, diagnostic instruments, and biochemicals, integrating R&D, production, and sales.
Company ProfileBeijing Leadman Biochemistry Co., Ltd. (hereinafter referred to as Leadman) was founded in November 1997 and successfully listed on the Shenzhen Stock Exchange ChiNext Board on February 16, 2012, stock code: 300289. The company's headquarters is located in the Beijing Economic-Technological Development Area, equipped with an R&D center and reference laboratory meeting international advanced standards, and has successfully passed the quality system assessment by the Beijing Medical Products Administration. Leadman has established one wholly-owned subsidiary in China and built a nationwide distributor network.

Stock Details

1. Key Indicators

  • Total Shares(W): 54401.15
  • Circulating A-Shares(W): 54315.65
  • Earnings Per Share(RMB): -0.0131
  • Net Assets Per Share(RMB): 3.0422
  • Operating Revenue(W RMB): 25224.34
  • Total Profit(W RMB): -368.68
  • Net Profit Attributable to Parent(W RMB): -713.48
  • Net Profit Growth Rate(%): -765.83
  • Weighted Return on Equity(%): -0.4300
  • Operating Cash Flow Per Share(RMB): 0.0180
  • Undistributed Profit Per Share(RMB): 0.7817
  • Capital Reserve Per Share(RMB): 1.1228

2. Main Business

The main business covers:

  • Research, production, and sales of in vitro diagnostic reagents
  • Research, production, and sales of diagnostic instruments
  • Research, production, and sales of biochemical raw materials

3. Company Basic Information

  • Company Name: Beijing Leadman Biochemistry Co., Ltd.
  • Listing Date: 2012-02-16
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 5 Xinghai Road, Beijing Economic-Technological Development Area, Beijing, China
  • Website: www.leadmanbio.com
  • Company Profile：The company was established through the overall change of Beijing Leadman Biochemistry Technology Co., Ltd. Based on an audit report, the company converted its net assets of RMB 81,586,099.01 as of June 30, 2009, into 72 million shares, with the shareholding ratio of each shareholder remaining unchanged before and after the change. The portion of net asset value exceeding the registered capital was recorded as the company's capital reserve. On July 21, 2009, the company completed the industrial and commercial change registration with the Beijing Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou High-tech Zone Technology Holding Group Co., Ltd. General Legal Person 25213.32 46.42
2 Yongying CSI All Share Medical Devices ETF Fund 201.13 0.37
3 Abu Dhabi Investment Authority QFII 129.11 0.24
4 MORGAN STANLEY & CO.INTERNATIONAL PLC. QFII 123.17 0.23

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Cold Chain Logistics
  • Assisted Reproduction
  • Continuous Loss
  • Restructuring Plan
  • QFII New Entry

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information